Substantially reduced life expectancy in patients with hidradenitis suppurativa: A Finnish nationwide registry study

Abstract

Hidradenitis suppurativa (HS) is associated with severe comorbidities,^1,2 but has not previously been subject to a systematic evaluation of mortality risk. We conducted a retrospective registry‐based case‐control study to describe life expectancy and cause‐specific death risks in patients with HS.

This article is protected by copyright. All rights reserved.

http://bit.ly/2EYpcDV